394 - Safety and Effectiveness of Long-Acting Cabotegravir/Rilpivirine in People with HIV and Severe Renal Impairment (CAPRI Trial)

Presenting Author(s)

• AS

  Alyssa Shon, MD

  Clinical Assistant Professor
  University at Buffalo
  Buffalo, New York, United States

  Slides

Co-Author(s)

• Ch

  Chiu-bin hsiao, MD

  Allegheny General Hospital, Positive Health clinic, Center for Inclusion Health, AHN; Drexel University, College of Medicine
  Pittsburgh, Pennsylvania, United States
• CO

  Cassandra Oehler, MD

  Allegheny General Hospital, Positive Health Clinic, Center for Inclusion Health, AHN, Drexel University College of Medicine
  Pittsburgh, Pennsylvania, United States
• XT

  Xuemei Tang, MD

  University at Buffalo
  Buffalo, New York, United States
• JR

  Jessica Ren, BS

  University at Buffalo
  Buffalo, New York, United States
• QM

  Qing Ma, PharmD, PhD

  University at Buffalo
  Buffalo, New York, United States